Miletich J P, Jackson C M, Majerus P W
Proc Natl Acad Sci U S A. 1977 Sep;74(9):4033-6. doi: 10.1073/pnas.74.9.4033.
When human 125I-labeled Factor Xa is incubated with washed platelets, prothrombin, and Ca2+, a small amount of thrombin is formed which causes the platelet release reaction after a period of time that decreases as the Xa concentration is increased from 0.9 to 19 ng/ml. After a further lag period, the Xa binds reversibly to receptors on the platelet surface and rapid thrombin formation follows (3 units or 1 mug of thrombin formed per min per ng of Xa bound to 10(8) platelets). When platelets are treated with either htrombin (0.5 units/ml) or calcium ionophore A23187 prior to addition of Xa, binding begins immediately. Thrombin formation occurs at the platelet surface at rates that correlate with the amount of Xa bound. Dibutyryl cyclic AMP inhibits the release reaction, Xa binding, and rate of thrombin generation in parallel. The platelet Xa receptor is distinct from the previously described thrombin receptor and appears to be a protein because treatment of platelets with thrombin at 50 units/ml destroys Xa binding sites. The results suggest that specific receptors for Xa appear on the platelet surface after the release reaction occurs. The bound Xa catalyzes thrombin formation 1000-fold faster than does Xa added to reactions in which phospholipids are substituted for platelets.
当将人125I标记的因子Xa与洗涤过的血小板、凝血酶原和Ca2+一起温育时,会形成少量凝血酶,经过一段时间后会引发血小板释放反应,随着Xa浓度从0.9 ng/ml增加到19 ng/ml,这段时间会缩短。在进一步的延迟期后,Xa可逆地结合到血小板表面的受体上,随后迅速形成凝血酶(每与10(8)个血小板结合的每纳克Xa每分钟形成3单位或1微克凝血酶)。当在添加Xa之前用凝血酶(0.5单位/ml)或钙离子载体A23187处理血小板时,结合立即开始。凝血酶在血小板表面以与结合的Xa量相关的速率形成。二丁酰环磷酸腺苷平行抑制释放反应、Xa结合和凝血酶生成速率。血小板Xa受体与先前描述的凝血酶受体不同,似乎是一种蛋白质,因为用50单位/ml的凝血酶处理血小板会破坏Xa结合位点。结果表明,Xa的特异性受体在释放反应发生后出现在血小板表面。结合的Xa催化凝血酶形成的速度比添加到用磷脂替代血小板的反应中的Xa快1000倍。